Nokia

About: Nokia is a company organization based out in Espoo, Finland. It is known for research contribution in the topics: Signal & Mobile station. The organization has 16625 authors who have published 28347 publications receiving 695725 citations. The organization is also known as: Nokia Oyj & Oy Nokia Ab.

System and method for generating a list of devices in physical proximity of a terminal

Abstract: This invention relates to generating a list of devices in physical proximity of each other and utilizing said list, for example, for sharing of content between a plurality of mobile devices applying individual media items such as address book entries, calendar entries, and/or Short Messaging Services (SMS) or Multimedia Messaging Services (MMS) messages.

Efficient mutual data authentication using manually authenticated strings

Abstract: Solutions for an easy and secure setup of a wireless connection between two devices are urgently needed for WLAN, Wireless USB, Bluetooth and similar standards for short range wireless communication. All such key exchange protocols employ data authentication as an unavoidable subtask. As a solution, we propose an asymptotically optimal protocol family for data authentication that uses short manually authenticated out-of-band messages. Compared to previous articles by Vaudenay and Pasini the results of this paper are more general and based on weaker security assumptions. In addition to providing security proofs for our protocols, we focus also on implementation details and propose practically secure and efficient sub-primitives for applications.

Method for sending a secure message in a telecommunications system

Abstract: A method for sending a secure message in a telecommunications system using public encryption keys. A sending transceiver encrypts the message c using the sender's own public encryption key Ex to generate Ex(c), and, transmits the encrypted message Ex(c) to a receiving transceiver. The receiving transceiver then encrypts the encrypted message Ex(c) using the encryption key Ey of the intended receiver of the message to generate the message Ey(Ex(c)), and, transmits the message Ey(Ex(c)) back to the sending transceiver. The sending transceiver then decrypts the message Ey(Ex(c)) using sender's private decryption key to generate Dx(Ey(Ex(c))) = Ey(c), and, transmits the message Ey(c) back to the receiving transceiver. The receiving transceiver then either decrypts the message using its own decryption key Dy, if it is the intended receiver of the message, to generate Dy(Ey(c)) = c, or, forwards the message on to the intended receiver of the message, if it is not the intended receiver of the message, where the intended receiver decrypts the message using its own decryption key Dy.

Visions of 4G

Abstract: As the Virtual Centre of Excellence in Mobile and Personal Communications (Mobile VCE) moves into its second core research programme it has been decided to set up a fourth generation (4G) Visions Group aimed at harmonising the research work across the work areas and amongst the numerous researchers working on the programme. This paper outlines the initial work of the group and provides a start to what will become an evolving vision of 4G. A short history of previous generations of mobile communications systems and a discussion of the limitations of third generation (3G) systems are followed by a vision of 4G for 2010 based around five elements: fully converged services, ubiquitous mobile access, diverse user devices, autonomous networks and software dependency. This vision is developed in more detail from a technology viewpoint into the key areas of networks and services, software systems and wireless access. It has been based upon a set of user scenarios that have been developed elsewhere in the Mobile VCE but which are summarised in the paper.

Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy

Abstract: Background Hypertension (HTN) is a common toxicity of anti-VEGF (vascular endothelial growth factor) antibody treatment. It may be a marker of VEGF signalling pathway inhibition and therefore represent a cancer biomarker in metastatic colorectal cancer (mCRC) patients treated with chemotherapy and bevacizumab. Methods A total of 101 consecutive patients with mCRC were treated with standard chemotherapy combined with bevacizumab at dose of 2.5 mg kg(-1) per week in a single centre. The median follow-up time of the patients alive was 64 months. Blood pressure was measured before each bevacizumab infusion, and HTN was graded according to common toxicity criteria for adverse events version 3.0. Results Overall, 57 patients (56%) developed ≥grade 1 HTN (median blood pressure 168/97 mm Hg), whereas 44 (44%) remained normotensive when treated with bevacizumab-containing chemotherapy regimen. Overall response rate was higher among patients with HTN (30 vs 20%; P=0.025). Hypertension was associated with improved progression-free survival (10.5 vs 5.3 months; P=0.008) and overall survival (25.8 vs 11.7 months; P Conclusion Hypertension may predict outcome of bevacizumab-containing chemotherapy in mCRC. These data require confirmation in prospective studies including pharmacodynamic and pharmacokinetic analyses.